Home LiteratureArticle Details
PMID: 27069549 Published · epublish English Journal Article

Wide-ranging alterations in the brain fatty acid complement of subjects with late Alzheimer's disease as detected by GC-MS.

American journal of translational research ·Vol. 8 ·No. 1 ·2016-00-00 ·Pages 154-65

Nasaruddin ML, Hölscher C, Kehoe P, Graham SF, Green BD

Abstract

Disturbed lipid metabolism is a well-established feature of human Alzheimer's disease (AD). The present study used gas chromatography-mass spectrometry (GC-MS) analysis of fatty acid methyl esters (FAMES) to profile all detectable fatty acid (FA) species present in post-mortem neocortical tissue (Brodmann 7 region). Quantitative targeted analysis was undertaken from 29 subjects (n=15 age-matched controls; n=14 late-stage AD). GC-MS analysis of FAMES detected a total of 24 FAs and of these, 20 were fully quantifiable. The results showed significant and wide ranging elevations in AD brain FA concentrations. A total of 9 FAs were elevated in AD with cis-13,16-docosenoic acid increased most (170%; P=0.033). Intriguingly, docosahexanoic acid (DHA; C22:6) concentrations were elevated (47%; P=0.018) which conflicts with the findings of others (unaltered or decreased) in some brain regions after the onset of AD. Furthermore, our results appear to indicate that subject gender influences brain FA levels in AD subjects (but not in age-matched control subjects). Among AD subjects 7 FA species were significantly higher in males than in females. These preliminary findings pinpoint FA disturbances as potentially important in the pathology of AD. Further work is required to determine if such changes are influenced by disease severity or different types of dementia.

Keywords
AD DHA Fatty acid GC-MS brain tissues
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Nasaruddin Muhammad Luqman
Institute for Global Food Security (IGFS), Queen's University Belfast Stranmillis Road, Belfast Northern Ireland, BT9 6AG, UK.
Hölscher Christian
Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University Lancaster LA1 4YQ, UK.
Kehoe Patrick
Dementia Research Group, Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Frenchay Hospital Bristol, UK.
Graham Stewart Francis
Beaumont Research Institute, Beaumont Health 3811 West 13 Mile Road, Royal Oak, Michigan 48073, USA.
Green Brian Desmond
Institute for Global Food Security (IGFS), Queen's University Belfast Stranmillis Road, Belfast Northern Ireland, BT9 6AG, UK.
References (50)
50 references, click to expand
  1. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.
    PLoS One. 2010 Nov 15;5(11):e13950 PMID: 21085570
  2. Protein-lipid interactions and phosphoinositide metabolism in membrane traffic: insights from vesicle recycling in nerve terminals.
    Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8262-9 PMID: 15146067
  3. Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease.
    Neurochem Res. 2010 Mar;35(3):503-13 PMID: 19904605
  4. Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers.
    Lipids. 2004 Nov;39(11):1125-32 PMID: 15726828
  5. Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease.
    Anal Chem. 2013 Feb 5;85(3):1803-11 PMID: 23252551
  6. Polyunsaturated fatty acids, neuroinflammation and well being.
    Prostaglandins Leukot Essent Fatty Acids. 2010 Apr-Jun;82(4-6):295-303 PMID: 20227866
  7. Palmitic acid increases apoptosis of neural stem cells via activating c-Jun N-terminal kinase.
    Stem Cell Res. 2013 Mar;10(2):257-66 PMID: 23319068
  8. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
    Proc Natl Acad Sci U S A. 1989 Oct;86(19):7611-5 PMID: 2529544
  9. Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease.
    Nat Rev Neurosci. 2011 Feb;12(2):65-72 PMID: 21193853
  10. Lipidomics: potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease.
    Pharmacol Ther. 2014 Jul;143(1):12-23 PMID: 24509229
  11. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease.
    J Alzheimers Dis. 2012;29(3):691-7 PMID: 22466064
  12. The opposing effects of n-3 and n-6 fatty acids.
    Prog Lipid Res. 2008 Mar;47(2):147-55 PMID: 18198131
  13. Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry.
    J Neurochem. 2001 May;77(4):1168-80 PMID: 11359882
  14. Health implications of high dietary omega-6 polyunsaturated Fatty acids.
    J Nutr Metab. 2012;2012:539426 PMID: 22570770
  15. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.
    Nat Rev Drug Discov. 2011 Aug 19;10(9):698-712 PMID: 21852788
  16. Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics.
    PLoS One. 2011;6(7):e21643 PMID: 21779331
  17. Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology.
    J Lipid Res. 2012 Mar;53(3):567-76 PMID: 22203775
  18. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.
    J Clin Invest. 2005 Oct;115(10 ):2774-83 PMID: 16151530
  19. In-vivo measurement of activated microglia in dementia.
    Lancet. 2001 Aug 11;358(9280):461-7 PMID: 11513911
  20. Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease.
    Neurobiol Aging. 2012 Jun;33(6):1057-66 PMID: 20980076
  21. Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease.
    PLoS One. 2011;6(10):e24777 PMID: 22046234
  22. Phosphoinositides, key molecules for regulation of actin cytoskeletal organization and membrane traffic from the plasma membrane.
    Biochim Biophys Acta. 2001 Oct 31;1533(3):190-206 PMID: 11731330
  23. GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease.
    Nat Med. 1995 Oct;1(10):1062-6 PMID: 7489364
  24. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids.
    Nutr Rev. 2010 May;68(5):280-9 PMID: 20500789
  25. Dairy calcium intake, serum vitamin D, and successful weight loss.
    Am J Clin Nutr. 2010 Nov;92(5):1017-22 PMID: 20810979
  26. Plasma phospholipids identify antecedent memory impairment in older adults.
    Nat Med. 2014 Apr;20(4):415-8 PMID: 24608097
  27. Polyunsaturated fatty acids and their metabolites in brain function and disease.
    Nat Rev Neurosci. 2014 Dec;15(12):771-85 PMID: 25387473
  28. The global prevalence of dementia: a systematic review and metaanalysis.
    Alzheimers Dement. 2013 Jan;9(1):63-75.e2 PMID: 23305823
  29. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease.
    Biochemistry. 2002 Sep 17;41(37):11080-90 PMID: 12220172
  30. Palmitic and stearic fatty acids induce Alzheimer-like hyperphosphorylation of tau in primary rat cortical neurons.
    Neurosci Lett. 2005 Aug 26;384(3):288-93 PMID: 15939536
  31. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models.
    PLoS One. 2011 Jan 05;6(1):e15816 PMID: 21246057
  32. Lipidomics of Alzheimer's disease.
    Bioanalysis. 2014 Feb;6(4):541-61 PMID: 24568356
  33. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation.
    J Biol Chem. 2003 Apr 25;278(17):14677-87 PMID: 12590139
  34. Trans fatty acids enhance amyloidogenic processing of the Alzheimer amyloid precursor protein (APP).
    J Nutr Biochem. 2012 Oct;23 (10 ):1214-23 PMID: 22209004
  35. Antioxidant and cyclooxygenase activities of fatty acids found in food.
    J Agric Food Chem. 2002 Apr 10;50(8):2231-4 PMID: 11929276
  36. Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway.
    J Cell Biol. 2004 Jan 5;164(1):123-31 PMID: 14709545
  37. A simple method for the isolation and purification of total lipides from animal tissues.
    J Biol Chem. 1957 May;226(1):497-509 PMID: 13428781
  38. The emerging role of docosahexaenoic acid in neuroinflammation.
    Curr Opin Investig Drugs. 2008 Jul;9(7):735-43 PMID: 18600579
  39. Inositol trisphosphate and calcium signaling.
    Ann N Y Acad Sci. 1995 Sep 7;766:31-43 PMID: 7486679
  40. Molecular circuits of resolution: formation and actions of resolvins and protectins.
    J Immunol. 2005 Apr 1;174(7):4345-55 PMID: 15778399
  41. Lipoxins and new lipid mediators in the resolution of inflammation.
    Curr Opin Pharmacol. 2006 Aug;6(4):414-20 PMID: 16750421
  42. The link between altered cholesterol metabolism and Alzheimer's disease.
    Ann N Y Acad Sci. 2012 Jul;1259:54-64 PMID: 22758637
  43. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion.
    Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1751-6 PMID: 12578976
  44. Mitochondrial membrane lipid remodeling in pathophysiology: a new target for diet and therapeutic interventions.
    Prog Lipid Res. 2013 Oct;52(4):513-28 PMID: 23827885
  45. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.
    J Exp Med. 2002 Oct 21;196(8):1025-37 PMID: 12391014
  46. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2070-5 PMID: 14970312
  47. Phospholipase A2 and arachidonic acid in Alzheimer's disease.
    Biochim Biophys Acta. 2010 Aug;1801(8):784-90 PMID: 20553961
  48. Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice.
    PLoS One. 2012;7(5):e36861 PMID: 22662127
  49. Essential fatty acids and the brain: possible health implications.
    Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):383-99 PMID: 10817922
  50. Evidence for a membrane defect in Alzheimer disease brain.
    Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1671-5 PMID: 1311847
Article Info
Journal
American journal of translational research
Abbr.
Am J Transl Res
ISSN
1943-8141
Published
2016-00-00
Epub
2016-00-15
Pages
154-65
Language
English
Region
United States
NLM ID
101493030
PMCID
PMC4759425
Grants
Medical Research Council · G0400074 · United Kingdom
Medical Research Council · G0502157 · United Kingdom
Medical Research Council · G0900652 · United Kingdom
Medical Research Council · G1100540 · United Kingdom
External Links
PubMed source PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2